Skip to content

Bright Light as a Countermeasure for Circadian Desynchrony

Bright Light as a Countermeasure for Circadian Desynchrony

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01119365
Enrollment
300
Registered
2010-05-07
Start date
2011-07-31
Completion date
2023-06-30
Last updated
2022-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Healthy controls

Brief summary

Light is the primary means by which the internal circadian clock remains aligned (entrained) with the external world. Misalignment of this internal clock can occur during situations such as shift work and jet travel across multiple time zones (jet lag). The purpose of this study is to examine how sequences of brief flashes of light can affect entrainment of the clock.

Interventions

Light is administered through a custom designed mask with LED lights.

Sponsors

Stanford University
CollaboratorOTHER
Palo Alto Veterans Institute for Research
CollaboratorOTHER
VA Palo Alto Health Care System
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

The investigator is unaware of specific sequence of light that is given to the participant until all data are analyzed.

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Good health * Normal hearing

Exclusion criteria

* Sleep disorder * Extreme chronotype * Regular smoker * Depression * Alcohol abuse * Illegal drug use

Design outcomes

Primary

MeasureTime frameDescription
Circadian phase2 daysThe timing of the onset of melatonin is compared before and after a light stimulus

Secondary

MeasureTime frameDescription
Alertness1 hourAlertness as assessed through change in brain wave (electroencephalographic, EEG) activity, questionnaires, and objective testing is examined before and at the end of a light stimulus

Countries

United States

Contacts

Primary ContactMarisol Duran
mreinoso@pavir.org650-493-5000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026